Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000966892> ?p ?o ?g. }
- W2000966892 endingPage "186" @default.
- W2000966892 startingPage "181" @default.
- W2000966892 abstract "1. The ability of olanzapine to inhibit the metabolism of marker catalytic activities for the cytochromes P450 CYP3A, CYP2D6, CYP2C9, and CYP2C19 was examined. This inhibitory capability was compared with that obtained with clozapine and known inhibitory compounds for the same cytochromes P450. 2. Olanzapine, clozapine, and ketoconazole were all found to non-competitively inhibit 1'-hydroxy midazolam formation, form selective for CYP3A, yielding Ki values of 491, 99 and 0.11 microM, respectively. The 1'-hydroxylation of bufuralol, form selective for CYP2D6, was competitively inhibited by olanzapine (Ki = 89 microM), clozapine (Ki = 19 microM), and quinidine (Ki = 0.03 microM). Tolbutamide metabolism to 4-hydroxy tolbutamide, form selective for CYP2C9, was competitively inhibited by clozapine and phenytoin (Ki of 31 microM and 17 microM, respectively). Olanzapine non-competitively inhibited tolbutamide metabolism with a Ki of 715 microM. The marker catalytic activity for CYP2C19 mediated metabolism, 4'-hydroxy S-mephenytoin formation, was competitively inhibited by clozapine (Ki = 69 microM) and omeprazole (Ki = 4.1 microM). Non-competitive inhibition of CYP2C19 mediated metabolism was seen with olanzapine with a Ki of 920 microM. 3. The calculated percent inhibition by olanzapine of substrates metabolized by CYP3A, CYP2D6, CYP2C9, and CYP2C19 was modeled assuming a total plasma concentration in the therapeutic range (0.2 microM). Total olanzapine vs unbound olanzapine was used to model the worst case (most conservative) situation. In all cases, the calculated percent inhibition of these cytochromes P450 by olanzapine was < 0.3%, suggesting that there would be little in vivo inhibition of the metabolism of substrates of these enzymes when co-administered with olanzapine." @default.
- W2000966892 created "2016-06-24" @default.
- W2000966892 creator A5010751291 @default.
- W2000966892 creator A5013434103 @default.
- W2000966892 creator A5071506935 @default.
- W2000966892 creator A5083182269 @default.
- W2000966892 date "1996-03-01" @default.
- W2000966892 modified "2023-09-27" @default.
- W2000966892 title "In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A" @default.
- W2000966892 cites W1544140936 @default.
- W2000966892 cites W1563004338 @default.
- W2000966892 cites W1576888146 @default.
- W2000966892 cites W161985329 @default.
- W2000966892 cites W1969215912 @default.
- W2000966892 cites W1975242893 @default.
- W2000966892 cites W1979392961 @default.
- W2000966892 cites W1993558201 @default.
- W2000966892 cites W1995647565 @default.
- W2000966892 cites W2045581755 @default.
- W2000966892 cites W2046016593 @default.
- W2000966892 cites W2050329206 @default.
- W2000966892 cites W2057467439 @default.
- W2000966892 cites W2059293500 @default.
- W2000966892 cites W2080126574 @default.
- W2000966892 cites W2082907683 @default.
- W2000966892 cites W2085360366 @default.
- W2000966892 cites W2102968881 @default.
- W2000966892 cites W2139217603 @default.
- W2000966892 cites W4300429786 @default.
- W2000966892 doi "https://doi.org/10.1111/j.1365-2125.1996.tb00180.x" @default.
- W2000966892 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8866916" @default.
- W2000966892 hasPublicationYear "1996" @default.
- W2000966892 type Work @default.
- W2000966892 sameAs 2000966892 @default.
- W2000966892 citedByCount "94" @default.
- W2000966892 countsByYear W20009668922012 @default.
- W2000966892 countsByYear W20009668922014 @default.
- W2000966892 countsByYear W20009668922016 @default.
- W2000966892 countsByYear W20009668922017 @default.
- W2000966892 countsByYear W20009668922020 @default.
- W2000966892 countsByYear W20009668922021 @default.
- W2000966892 countsByYear W20009668922022 @default.
- W2000966892 countsByYear W20009668922023 @default.
- W2000966892 crossrefType "journal-article" @default.
- W2000966892 hasAuthorship W2000966892A5010751291 @default.
- W2000966892 hasAuthorship W2000966892A5013434103 @default.
- W2000966892 hasAuthorship W2000966892A5071506935 @default.
- W2000966892 hasAuthorship W2000966892A5083182269 @default.
- W2000966892 hasConcept C11824378 @default.
- W2000966892 hasConcept C118552586 @default.
- W2000966892 hasConcept C134018914 @default.
- W2000966892 hasConcept C150757390 @default.
- W2000966892 hasConcept C181199279 @default.
- W2000966892 hasConcept C185592680 @default.
- W2000966892 hasConcept C2776054734 @default.
- W2000966892 hasConcept C2776412080 @default.
- W2000966892 hasConcept C2776619155 @default.
- W2000966892 hasConcept C2780864610 @default.
- W2000966892 hasConcept C33664856 @default.
- W2000966892 hasConcept C3946865 @default.
- W2000966892 hasConcept C526171541 @default.
- W2000966892 hasConcept C55493867 @default.
- W2000966892 hasConcept C555293320 @default.
- W2000966892 hasConcept C62231903 @default.
- W2000966892 hasConcept C71924100 @default.
- W2000966892 hasConcept C86803240 @default.
- W2000966892 hasConcept C98274493 @default.
- W2000966892 hasConceptScore W2000966892C11824378 @default.
- W2000966892 hasConceptScore W2000966892C118552586 @default.
- W2000966892 hasConceptScore W2000966892C134018914 @default.
- W2000966892 hasConceptScore W2000966892C150757390 @default.
- W2000966892 hasConceptScore W2000966892C181199279 @default.
- W2000966892 hasConceptScore W2000966892C185592680 @default.
- W2000966892 hasConceptScore W2000966892C2776054734 @default.
- W2000966892 hasConceptScore W2000966892C2776412080 @default.
- W2000966892 hasConceptScore W2000966892C2776619155 @default.
- W2000966892 hasConceptScore W2000966892C2780864610 @default.
- W2000966892 hasConceptScore W2000966892C33664856 @default.
- W2000966892 hasConceptScore W2000966892C3946865 @default.
- W2000966892 hasConceptScore W2000966892C526171541 @default.
- W2000966892 hasConceptScore W2000966892C55493867 @default.
- W2000966892 hasConceptScore W2000966892C555293320 @default.
- W2000966892 hasConceptScore W2000966892C62231903 @default.
- W2000966892 hasConceptScore W2000966892C71924100 @default.
- W2000966892 hasConceptScore W2000966892C86803240 @default.
- W2000966892 hasConceptScore W2000966892C98274493 @default.
- W2000966892 hasIssue "3" @default.
- W2000966892 hasLocation W20009668921 @default.
- W2000966892 hasLocation W20009668922 @default.
- W2000966892 hasOpenAccess W2000966892 @default.
- W2000966892 hasPrimaryLocation W20009668921 @default.
- W2000966892 hasRelatedWork W1493745198 @default.
- W2000966892 hasRelatedWork W2000966892 @default.
- W2000966892 hasRelatedWork W2100139561 @default.
- W2000966892 hasRelatedWork W2152636853 @default.
- W2000966892 hasRelatedWork W2769392924 @default.
- W2000966892 hasRelatedWork W2919600216 @default.
- W2000966892 hasRelatedWork W2954696203 @default.